Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model

Arrhythmogenic cardiomyopathy (ACM) is a rare genetic disease associated with ventricular arrhythmias in patients. The occurrence of these arrhythmias is due to direct electrophysiological remodeling of the cardiomyocytes, namely a reduction in the action potential duration (APD) and a disturbance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Reisqs, Jean-Baptiste, Moreau, Adrien, Sleiman, Yvonne, Charrabi, Azzouz, Delinière, Antoine, Bessière, Francis, Gardey, Kevin, Richard, Sylvain, Chevalier, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960914/
https://www.ncbi.nlm.nih.gov/pubmed/36836569
http://dx.doi.org/10.3390/jpm13020335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960914/
https://www.ncbi.nlm.nih.gov/pubmed/36836569
http://dx.doi.org/10.3390/jpm13020335

Ejemplares similares